Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma”

504 trials

Showing 20 of 504 results

Early research (Phase 1)Not Yet RecruitingNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Testing effectiveness (Phase 2)Study completedNCT00028795
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 170
Early research (Phase 1)Study completedNCT01729260
What this trial is testing

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide

Who this might be right for
Newly Diagnosed High-Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Early research (Phase 1)Study completedNCT01180816
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 21
Testing effectiveness (Phase 2)Study completedNCT00525525
What this trial is testing

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
University of California, San Francisco 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04373785
What this trial is testing

NG101m Adjuvant Therapy in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme
NeuGATE Theranostics 52
Large-scale testing (Phase 3)Temporarily pausedNCT02546102
What this trial is testing

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 234
Testing effectiveness (Phase 2)Study completedNCT00441142
What this trial is testing

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Patrick Y. Wen, MD 119
Testing effectiveness (Phase 2)Ended earlyNCT03018288
What this trial is testing

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00684567
What this trial is testing

Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT03276286
What this trial is testing

Nativis Voyager for Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
Nativis, Inc. 37
Testing effectiveness (Phase 2)UnknownNCT05447195
What this trial is testing

Phase 2 Study of CAN008 in Subjects With GBM

Who this might be right for
Newly-diagnosed Glioblastoma
CANbridge Life Sciences Ltd. 117
Very early researchLooking for participantsNCT06072586
What this trial is testing

BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Who this might be right for
High Grade GliomaGlioblastoma
St. Joseph's Hospital and Medical Center, Phoenix 82
Testing effectiveness (Phase 2)Study completedNCT00187486
What this trial is testing

Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
University of California, San Francisco 66
Very early researchNot Yet RecruitingNCT07387666
What this trial is testing

Imaging Acetadote Metabolism in Glioblastoma

Who this might be right for
GlioblastomaGBM
University of Texas Southwestern Medical Center 10
Not applicableUnknownNCT04717739
What this trial is testing

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Who this might be right for
Glioblastoma
NovoCure Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT02715609
What this trial is testing

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Washington University School of Medicine 35
Early research (Phase 1)Looking for participantsNCT07141732
What this trial is testing

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Who this might be right for
Glioblastoma
Joint Stock Company European Medical Centre 15
Testing effectiveness (Phase 2)UnknownNCT00394628
What this trial is testing

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Novacea 60
Not applicableStudy completedNCT01653834
What this trial is testing

Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

Who this might be right for
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation